This week's roundup of Houston innovators includes Jessica Traver Ingram of IntuiTap, Kelsey Ruger of Hello Alice, Katy Rezvani of MD Anderson Cancer Center. Photos courtesy

Editor's note: Every week, I introduce you to three Houston innovators to know recently making headlines with news of innovative technology, investment activity, and more. This week's batch includes a podcast with a health tech founder, advice from an AI expert, and a cancer-fighting innovator.

Jessica Traver Ingram, CEO and co-founder of IntuiTap

Jessica Traver Ingram, CEO and co-founder of IntuiTap, joins the Houston Innovators Podcast to share her company's latest milestone. Photo courtesy of IntuiTap

Jessica Traver Ingram has been captivated by the intersection of physics and health care for most of her life, and that passion led her to contributing to the establishment of the Texas Medical Center's Biodesign Fellowship. After helping make the program a reality, Traver Ingram then participated in it as a fellow.

The program selects fellows and then lets them explore the TMC's member institutions to find ways to innovate within unmet clinical needs, and the inefficiency and challenges with placing epidurals and lumbar punctures caught Traver Ingram and her cohort's eye. The process relies completely on the health care practitioner's ability to feel the spine with their fingers to make the injection.

"We kept watching the inefficiencies of these procedures, and everyone was like, 'you're right, we don't really know why we do it this way,'" Traver Ingram says on the Houston Innovators Podcast. "It's really cool to be outsiders watching and observing, because you just see things other people don't see — and that's in any industry."

With that, IntuiTap was born. Traver Ingram describes its tool, the VerTouch, as a "stud finder for the spine." After years of growing the company, she can also now call it FDA-approved. Read more.


Kelsey Ruger, chief technology and product officer for Hello Alice

AI's true potential lies in its ability to enhance human capabilities, not replace them. Photo courtesy

Ready or not, artificial intelligence is coming. In fact, it's already affecting the workforce.

"With its ability to automate tasks, analyze large amounts of data, and provide detailed insights, AI offers an enormous opportunity for businesses of all sizes," writes Kelsey Ruger, chief technology and product officer for Hello Alice, in a guest column. "However, realizing this potential requires a strategic approach that positions AI as a powerful partner, rather than a replacement for human ingenuity."

Ruger shares how business can unlock AI's full potential via automation, augmentation, and autonomy. Read more.

Katy Rezvani, professor of stem cell transplantation and cellular therapy at MD Anderson Cancer Center

At Rezvani Lab in MD Anderson Cancer Center, scientists train immune cells to fight cancer. Photo courtesy

San Diego-based Replay incorporated a first-in-class engineered TCR-NK cell therapy product company, Syena, using technology developed by Dr. Katy Rezvani at The University of Texas MD Anderson Cancer Center. The company has announced that its first patient has been dosed with an engineered T-Cell Receptor Natural Killer (TCR-NK) cell therapy for relapsed or refractory multiple myeloma.

Rezvani, a professor of stem cell transplantation and cellular therapy, is the force behind MD Anderson’s Rezvani Lab, a group of 55 people, all focused on harnessing natural killer cells to combat cancer.

“Everybody thinks that the immune system is fighting viruses and infections, but I feel our immune system is capable of recognizing and killing abnormal cells or cells that are becoming cancerous and they're very powerful. This whole field of immunotherapy really refers to the power of the immune system,” Rezvani tells InnovationMap. Read more.

AI's true potential lies in its ability to enhance human capabilities, not replace them. Photo via Getty Images

Houston expert shares 3 strategies for integrating AI into the workforce

guest column

The rapid advancement of artificial intelligence is forcing businesses to evaluate how they will manage the inevitable changes this technology will bring. With its ability to automate tasks, analyze large amounts of data, and provide detailed insights, AI offers an enormous opportunity for businesses of all sizes. However, realizing this potential requires a strategic approach that positions AI as a powerful partner, rather than a replacement for human ingenuity.

The British Council reports that an estimated 65 percent of today's students will eventually work in professions that have yet to be conceived. With the emergence of new AI, this projection emphasizes the importance of cultivating a versatile skill set that allows us to adapt to the ever-changing landscape. It also underscores the importance of having a strategy that embraces the division of labor between humans and machines.

What this means is that an AI strategy shouldn't just be about automation – it should also incorporate an understanding of the human-AI partnership that will be necessary for future success. By using the concepts of automation, augmentation, and autonomy, businesses can unlock the full potential of AI to boost efficiency, enhance decision-making, and ultimately drive continued success.

Automation: Delegating to the AI

We know AI can automate many tasks in a business. However, we should also look at automation from a strategy standpoint by asking, "What tasks can be fully delegated to the AI?" Answering this question might include considering routine, repetitive, and time-consuming tasks that shouldn't require human intervention or those that would be more susceptible to human error. The goal here should be to identify tasks that don't benefit from human nuance, meaning asking questions about time, precision, and compliance could offer even more value.

  • Time. What tasks are time-consuming and could be completed quickly with well-written instructions?
  • Precision. What tasks require precision that is difficult for humans to achieve?
  • Compliance. What tasks involve critical safety procedures or adherence to strict compliance that humans might overlook?

Augmentation: Using AI to boost your potential

Beyond automation, AI's true power lies in its ability to boost human capabilities. In this lens, you should ask, "How can the AI boost my output potential?" Think of AI as a skilled assistant that can analyze vast datasets, identify complex patterns, and present insights that aren't readily apparent to humans alone. The focus here is on tasks that still require a human touch but can benefit from computers' speed and data processing power. When exploring this further, consider asking questions about skill boosts, assistance, and focus.

  • Skill boosts. What tasks am I doing that I understand but need to be an expert at?
  • Assistance. What tasks still require a human's touch but could use processing or speed boosts?
  • Focus. What tasks are causing employees to spend more time on tools and less on goals?

Autonomy: The importance of humans in the loop

One question that comes up frequently when discussing AI is whether it will replace a particular set of jobs. My thoughts, however, are that while AI is remarkably powerful, the key to making all this work is understanding that not every task requires automation. In fact, some tasks would suffer from automation. This step requires you to ask, "Where are human emotion, creativity, intuition, and oversight essential?" Autonomy, in this sense, means digging into creativity, intuition, and uniqueness.

  • Creativity. Does this task require a level of creativity that a machine can't replicate?
  • Intuition. Does this task require emotional awareness that a machine can't discern?
  • Brand Uniqueness. Does this task represent a part of my brand that shouldn't be automated or machine-driven?

AI brings a lot to look forward to. It’s fair to say it’s on its way to transforming the world, but it's important to remember that the businesses that strategically embrace a human-centered approach to integrating AI into everyday business activities are the ones that will thrive. The three A’s: automation, augmentation, and autonomy, provide an essential foundation to begin this journey. By understanding the best applications for each aspect of AI, businesses of all sizes can discover areas for increased efficiency, more thoughtful decision-making, and a competitive edge that drives long-term success. AI's true potential lies in its ability to enhance human capabilities, not replace them.

------

Kelsey Ruger is the chief technology and product officer for Hello Alice.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

German biotech co. to relocate to Houston thanks to $4.75M CPRIT grant

money moves

Armed with a $4.75 million grant from the Cancer Prevention and Research Institute of Texas, a German biotech company will relocate to Houston to work on developing a cancer medicine that fights solid tumors.

Eisbach Bio is conducting a clinical trial of its EIS-12656 therapy at Houston’s MD Anderson Cancer Center. In September, the company announced its first patient had undergone EIS-12656 treatment. EIS-12656 works by suppressing cancer-related genome reorganization generated by DNA.

The funding from the cancer institute will support the second phase of the EIS-12656 trial, focusing on homologous recombination deficiency (HRD) tumors.

“HRD occurs when a cell loses its ability to repair double-strand DNA breaks, leading to genomic alterations and instability that can contribute to cancerous tumor growth,” says the institute.

HRD is a biomarker found in most advanced stages of ovarian cancer, according to Medical News Today. DNA constantly undergoes damage and repairs. One of the repair routes is the

homologous recombination repair (HRR) system.

Genetic mutations, specifically those in the BCRA1 and BCRA1 genes, cause an estimated 10 percent of cases of ovarian cancer, says Medical News Today.

The Cancer Prevention and Research Institute of Texas (CPRIT) says the Eisbach Bio funding will bolster the company’s “transformative approach to HRD tumor therapy, positioning Texas as a hub for innovative cancer treatments while expanding clinical options for HRD patients.”

The cancer institute also handed out grants to recruit several researchers to Houston:

  • $2 million to recruit Norihiro Goto from the Massachusetts Institute of Technology to MD Anderson.
  • $2 million to recruit Xufeng Chen from New York University to MD Anderson.
  • $2 million to recruit Xiangdong Lv from MD Anderson to the University of Texas Health Science Center at Houston.

In addition, the institute awarded:

  • $9,513,569 to Houston-based Marker Therapeutics for a first-phase study to develop T cell-based immunotherapy for treatment of metastatic pancreatic cancer.
  • $2,499,990 to Lewis Foxhall of MD Anderson for a colorectal cancer screening program.
  • $1,499,997 to Abigail Zamorano of the University of Texas Health Science Center at Houston for a cervical cancer screening program.
  • $1,497,342 to Jennifer Minnix of MD Anderson for a lung cancer screening program in Northeast Texas.
  • $449,929 to Roger Zoorob of the Baylor College of Medicine for early prevention of lung cancer.

On November 20, the Cancer Prevention and Research Institute granted funding of $89 million to an array of people and organizations involved in cancer prevention and research.

West Coast innovation organization unveils new location in Houston suburb to boost Texas tech ecosystem

plugging in

Leading innovation platform Plug and Play announced the opening of its new flagship Houston-area location in Sugar Land, which is its fourth location in Texas.

Plug and Play has accelerated over 2,700 startups globally last year with corporate partners that include Dell Technologies, Daikin, Microsoft, LG Chem, Shell, and Mercedes. The company’s portfolio includes PayPal, Dropbox, LendingClub, and Course Hero, with 8 percent of the portfolio valued at over $100 million.

The deal, which facilitated by the Sugar Land Office of Economic Development and Tourism, will bring a new office for the organization to Sugar Land Town Square with leasing and hiring between December and January. The official launch is slated for the first quarter of 2025, and will feature 15 startups announced on Selection Day.

"By expanding to Sugar Land, we’re creating a space where startups can access resources, build partnerships, and scale rapidly,” VP Growth Strategy at Plug and Play Sherif Saadawi says in a news release. “This location will help fuel Texas' innovation ecosystem, providing entrepreneurs with the tools and networks they need to drive real-world impact and contribute to the state’s technological and economic growth."

Plug and Play plans to hire four full-time equivalent employees and accelerate two startup batches per year. The focus will be on “smart cities,” which include energy, health, transportation, and mobility sectors. One Sugar Land City representative will serve as a board member.

“We are excited to welcome Plug and Play to Sugar Land,” Mayor of Sugar Land Joe Zimmerma adds. “This investment will help us connect with corporate contacts and experts in startups and businesses that would take us many years to reach on our own. It allows us to create a presence, attract investments and jobs to the city, and hopefully become a base of operations for some of these high-growth companies.”

The organization originally entered the Houston market in 2019 and now has locations in Bryan/College Station, Frisco, and Cedar Park in Texas.